Alterations in the PI3K/AKT/mTOR pathway are prevalent in hormonal breast cancer, over-activating the pathway and allowing uncontrolled tumor cell growth, resistance to apoptosis, and tumorigenesis [8,9]. The gene discussed is MTOR; the disease is neoplasm.